Skip to main content

Hydroxychloroquine annual eye exam

CBE ID
0585
1.4 Project
EENT Endorsement Maintenance
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
Previous Endorsement Cycle
Full Year 2014
Is Under Review
No
1.3 Measure Description

This measure identifies the percentage of patients with Rheumatoid Arthritis who received hydroxychloroquine during the measurement year and had a fundoscopic examination during the measurement year or in the year prior to the measurement year

    • 1.14 Numerator

      Patients in the denominator who have undergone a retinal eye exam or who have an E&M visit with an eye care professional during the measurement year

    • 1.15 Denominator

      Patients with a diagnosis of rheumatoid arthritis who are at high risk for hydroxychloroquine ocular complications and were prescribed at least a 292-day supply of hydroxychloroquine during the measurement year, excluding those with a prior history of blindness

    • Exclusions

      Blindness

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed EENT Endorsement Maintenance Project 2014
      Initial Endorsement
      Last Updated
      Removal Date
    • Steward
      Resolution Health, Inc.
      Steward Organization POC Email
      [email protected]